CardieX Ltd CDX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$0.07
- Day Range
- A$0.07–0.07
- 52-Week Range
- A$0.07–0.42
- Bid/Ask
- A$0.07 / A$0.07
- Market Cap
- A$20.89 Mil
- Volume/Avg
- 662,329 / 438,329
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.84
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
CardieX Ltd is a global health technology company, developing solutions for health disorders. The AtCor Medical division develops medical devices for measuring arterial stiffness and central blood pressure waveforms based on its patented SphygmoCor technology. It also develops and licenses its Arty platform consisting of physiological and health analytics for wearable devices. It reports in a single segment being sales of cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies. The company has three reportable segments by geographic area namely the Americas includes, global pharmaceutical trials business, Europe includes, the Middle East and Africa and the Asia Pacific includes, Asia and Australia/New Zealand.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 27
- Website
- https://www.cardiex.com
Valuation
|
Metric
|
CDX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 470.20 |
Price/Sales | 0.84 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CDX
|
|---|---|
Quick Ratio | 0.69 |
Current Ratio | 1.02 |
Interest Coverage | −9.91 |
Quick Ratio
CDX
Profitability
|
Metric
|
CDX
|
|---|---|
Return on Assets (Normalized) | −59.27% |
Return on Equity (Normalized) | −707.95% |
Return on Invested Capital (Normalized) | −128.75% |
Return on Assets
CDX
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Gwtbhqgrb | Wzdglc | $183.8 Bil | |
SYK
| Stryker Corp | Gkcsjnvdn | Kyndw | $127.8 Bil | |
MDT
| Medtronic PLC | Wzhxzgp | Rckyxn | $105.0 Bil | |
BSX
| Boston Scientific Corp | Tnmckjdll | Hnkjr | $99.9 Bil | |
EW
| Edwards Lifesciences Corp | Wbvghtsphz | Jmwgfx | $52.5 Bil | |
DXCM
| DexCom Inc | Fzcvblykk | Hsqvp | $51.9 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Sgjyvjcx | Qckhf | $24.9 Bil | |
ALGN
| Align Technology Inc | Jtdwvhwn | Gfyfhlq | $22.6 Bil | |
PHG
| Koninklijke Philips NV ADR | Nykxdprmq | Skcwbr | $18.2 Bil | |
PODD
| Insulet Corp | Yjwdgjmwzn | Lbxrb | $11.6 Bil |